ArticleNature communications2025
Coarctate reaction for synthesis of fluorescent N-heterocycles, late-stage functionalization, and photo-triggered drug delivery.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Coarctate reactions, involving the simultaneous formation and cleavage of two bonds at single or multiple atoms, have remained largely unexplored for biomolecular applications. These reactions are characterized by complex helical orbitals in their transition state and produce unique chemical entities unattainable by other methods. This makes coarctate reactions particularly useful for expanding the chemical diversity and properties of biomolecules. In this study, we apply an azo-ene-yne coarctate reaction to synthesize isoindazole-based N-heterocycles and explore their biomolecular applications. The azo-ene-yne coarctate method demonstrates high chemoselectivity, thus enabling the synthesis of unnatural amino acids and drug conjugates, and late-stage peptide functionalization. These isoindazole-based N-heterocycles exhibit inherent fluorescence, which can be enhanced and red-shifted through electronic tuning. Additionally, we discover a photo-triggered cleavage of the isoindazole moiety from 2-amine-isoindazole, enabling the light-triggered selective delivery of secondary amine and hydroxyl-containing drugs, which represent over 70% of current pharmaceuticals. We also employ a light-triggered method for the selective deprotection of secondary amines and the late-stage functionalization of peptides with isoindazole, enabling access to previously unexplored chemical space.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.